+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Active & Intelligent Packaging Market - Global Forecast 2026-2032- Product Image
Pharmaceutical Active & Intelligent Packaging Market - Global Forecast 2026-2032- Product Image
Sale

Pharmaceutical Active & Intelligent Packaging Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6279649
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Pharmaceutical Active and Intelligent Packaging: Executive Overview

Pharmaceutical active and intelligent packaging combines packaging functions that preserve product quality with systems that monitor, communicate, or respond to changing conditions. Active formats can regulate moisture, oxygen, light, or microbial exposure, while intelligent features can support identification, authentication, traceability, adherence, and condition monitoring. Adoption is shaped by medicine sensitivity, regulatory expectations, distribution complexity, sustainability requirements, and the need to protect patients across increasingly connected supply chains.

Packaging Shifts from Passive Protection to Connected Product Stewardship

The landscape is shifting toward packaging that contributes directly to product integrity and patient safety. Temperature indicators, time-temperature monitoring, tamper evidence, serialization, connected labels, and sensor-enabled components are becoming more relevant where conventional visual inspection cannot fully document storage history or product authenticity. At the same time, manufacturers and healthcare providers are balancing functionality with recyclability, material reduction, usability, data privacy, and compatibility with established filling and distribution processes. This transition favors modular solutions that can be validated without creating unnecessary operational complexity.

Artificial Intelligence Strengthens Detection, Compliance, and Patient Engagement

Artificial intelligence can increase the value of active and intelligent pharmaceutical packaging by interpreting data from sensors, cameras, connected labels, and supply-chain systems. Applied responsibly, AI can help identify abnormal temperature exposure, detect packaging defects, distinguish authentic products from suspicious units, prioritize quality investigations, and recognize adherence patterns. Its effectiveness depends on representative training data, validated algorithms, cybersecurity controls, explainable decisions, and clear accountability under pharmaceutical quality systems. AI should therefore complement, rather than replace, documented procedures, human review, and regulatory validation.

Regional Insights: Regulatory Rigor and Supply-Chain Conditions Shape Adoption

North America is characterized by advanced pharmaceutical logistics, strong serialization and traceability expectations, and interest in connected adherence and cold-chain monitoring. Latin America faces diverse regulatory and infrastructure conditions, making authentication, tamper evidence, and practical temperature visibility especially relevant across complex distribution networks. Europe emphasizes patient safety, environmental performance, data governance, and harmonized compliance, encouraging solutions that combine traceability with material efficiency. The Middle East is influenced by import dependence, high-value medicines, and climate conditions that increase the value of robust protection and monitoring. Africa presents varied infrastructure and healthcare-access conditions, creating demand for durable, low-complexity indicators and authentication tools. Asia-Pacific combines large manufacturing and patient populations with rapidly developing digital health and logistics capabilities, supporting differentiated adoption across mature and emerging supply chains.

Group Insights: Economic and Institutional Blocs Create Distinct Priorities

ASEAN markets reflect varied regulatory maturity, manufacturing capacity, and logistics infrastructure, so scalable authentication, temperature visibility, and interoperable data practices are important. BRICS members combine major pharmaceutical demand and production capabilities with differing compliance frameworks, favoring adaptable systems that address local operating conditions. The European Union places particular emphasis on harmonized regulation, supply-chain security, sustainability, and data protection. G7 economies generally support sophisticated serialization, quality-control, and patient-centric packaging applications, while requiring strong evidence and cybersecurity. GCC markets prioritize secure pharmaceutical distribution, climate resilience, and the integrity of imported medicines. NATO countries, considered as a broad group, also present requirements connected with resilient medical supply chains, secure data exchange, and continuity of medicine access.

Country Insights: Adoption Priorities Reflect National Healthcare and Manufacturing Contexts

Australia is positioned for applications supporting remote distribution, cold-chain assurance, and patient usability. Brazil and Mexico face diverse distribution conditions that increase the importance of authentication, tamper evidence, and practical monitoring. Canada emphasizes quality assurance across large distances and patient-friendly connected solutions. China combines extensive pharmaceutical manufacturing with strong interest in traceability, digital integration, and domestic supply-chain control. France, Germany, Italy, and Spain operate within European requirements while reflecting distinct manufacturing, healthcare-delivery, sustainability, and packaging practices. India’s broad and heterogeneous medicine-distribution network supports demand for affordable authentication, adherence support, and condition monitoring. Japan emphasizes precision, reliability, miniaturization, and usability for an aging population. Russia’s adoption environment is influenced by supply-chain resilience, domestic production priorities, and regulatory requirements. South Korea combines advanced electronics capabilities with digitally enabled healthcare and packaging applications. The United Kingdom emphasizes serialization, medicine security, sustainability, and digitally supported patient care. The United States remains focused on traceability, product integrity, cold-chain control, adherence, and integration with established pharmaceutical quality systems.

Action Agenda for Leaders: Validate Utility, Integrate Data, and Design for Scale

Industry leaders should begin with clearly defined risks-such as temperature excursions, counterfeiting, moisture exposure, or missed doses-and select packaging functions that address measurable outcomes. They should validate materials, indicators, sensors, and software within existing quality systems before broader deployment. Interoperability with enterprise, logistics, dispensing, and clinical workflows can prevent isolated data silos. Cybersecurity, privacy, access control, and lifecycle management should be designed into connected products from the outset. Leaders should also evaluate recyclability, material reduction, accessibility, and disposal behavior alongside performance. Pilots should use operational metrics such as excursion detection, investigation time, authentication accuracy, user comprehension, and compliance performance, with expansion governed by documented evidence.

Research Methodology: Evidence-Based Assessment of Packaging Transformation

This executive summary uses the defined market scope of pharmaceutical active and intelligent packaging and organizes findings across technology functions, pharmaceutical applications, regulatory considerations, supply-chain requirements, and adoption conditions. The assessment compares required regions, economic and institutional groups, and specified countries through qualitative analysis of their healthcare infrastructure, pharmaceutical manufacturing context, logistics characteristics, policy environment, sustainability priorities, and digital readiness. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific claims. Conclusions are framed as evidence-led strategic interpretations and should be validated against current regulations, technical standards, product-specific stability requirements, and local operating data before investment decisions.

Conclusion: Packaging Becomes an Evidence Layer for Pharmaceutical Quality

Active and intelligent packaging is evolving from a protective container into an evidence layer that can help preserve quality, verify authenticity, improve traceability, and support patient use. The strongest opportunities arise where packaging intelligence addresses a defined clinical, logistical, or regulatory problem without compromising usability, sustainability, or validated pharmaceutical processes. Regional and country differences mean that deployment should be tailored rather than uniform. Leaders that combine robust materials, reliable sensing, secure data practices, and measurable operational outcomes will be better positioned to build trusted packaging systems across increasingly complex medicine supply chains.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Pharmaceutical Active & Intelligent Packaging Market, by Packaging Material
7.1. Introduction
7.2. Composite Materials
7.2.1. Blister Foils
7.2.2. Laminates
7.3. Glass
7.3.1. Borosilicate
7.3.2. Soda Lime
7.4. Metal
7.4.1. Aluminum
7.4.2. Tinplate
7.5. Paperboard
7.5.1. Coated Paperboard
7.5.2. Folding Cartons
7.6. Plastic
7.6.1. HDPE
7.6.2. LDPE
8. Pharmaceutical Active & Intelligent Packaging Market, by Packaging Form
8.1. Introduction
8.2. Primary Packaging
8.2.1. Ampoules
8.2.2. Blister Packs
8.2.3. Bottles
8.2.4. Vials
8.3. Secondary Packaging
8.3.1. Cartons
8.3.2. Inserts
8.3.3. Trays
8.4. Tertiary Packaging
8.4.1. Pallets
8.4.2. Shippers
9. Pharmaceutical Active & Intelligent Packaging Market, by Drug Dosage Form
9.1. Introduction
9.2. Biologics
9.2.1. Monoclonal Antibodies
9.2.2. Vaccines
9.3. Parenteral
9.3.1. Infusion Bags
9.3.2. Injectable Vials
9.4. Solid Oral Dosage
9.4.1. Capsules
9.4.2. Tablets
9.5. Topical
9.5.1. Creams
9.5.2. Ointments
10. Pharmaceutical Active & Intelligent Packaging Market, by Function
10.1. Introduction
10.2. Monitoring
10.2.1. Environmental Monitoring
10.2.2. Integrity Monitoring
10.3. Preservation
10.3.1. Barrier Protection
10.3.2. Controlled Atmosphere
10.4. Protection
10.4.1. Light Protection
10.4.2. Mechanical Protection
11. Pharmaceutical Active & Intelligent Packaging Market, by Technology
11.1. Introduction
11.2. Active Technologies
11.2.1. Release Systems
11.2.2. Scavengers
11.3. Passive Technologies
11.3.1. Barrier Films
11.3.2. Coatings
11.4. Smart Technologies
11.4.1. IoT Enabled Devices
11.4.2. Printed Electronics
12. Pharmaceutical Active & Intelligent Packaging Market, by End User
12.1. Introduction
12.2. Contract Packaging Organizations
12.3. Hospitals And Clinics
12.4. Pharmaceutical Manufacturers
12.5. Retail Pharmacies
12.6. Wholesale Distributors
13. Pharmaceutical Active & Intelligent Packaging Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Pharmaceutical Active & Intelligent Packaging Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Pharmaceutical Active & Intelligent Packaging Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Amcor plc
17.2. Avery Dennison Corporation
17.3. Berry Global Group, Inc.
17.4. CCL Industries Inc.
17.5. Constantia Flexibles GmbH
17.6. Coveris Holdings SA
17.7. Huhtamäki Oyj
17.8. Schreiner Group GmbH & Co. KG
17.9. Sealed Air Corporation
17.10. Sonoco Products Company
17.11. Tetra Pak International S.A.
17.12. Uflex Limited
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Pharmaceutical Active & Intelligent Packaging Market, Years Considered for the Study
FIGURE 2. Global Pharmaceutical Active & Intelligent Packaging Market, Research Design
FIGURE 3. Global Pharmaceutical Active & Intelligent Packaging Market, Research Framework
FIGURE 4. Global Pharmaceutical Active & Intelligent Packaging Market, Data Triangulation
FIGURE 5. Global Pharmaceutical Active & Intelligent Packaging Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Packaging Material, 2025 vs 2032 (%)
FIGURE 7. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Packaging Material, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Packaging Form, 2025 vs 2032 (%)
FIGURE 9. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Packaging Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Drug Dosage Form, 2025 vs 2032 (%)
FIGURE 11. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Drug Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Function, 2025 vs 2032 (%)
FIGURE 13. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Function, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 15. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Pharmaceutical Active & Intelligent Packaging Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Pharmaceutical Active & Intelligent Packaging Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Pharmaceutical Active & Intelligent Packaging Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Pharmaceutical Active & Intelligent Packaging Market Segmentation & Coverage
TABLE 2. Global Pharmaceutical Active & Intelligent Packaging Market Size, 2017-2032 (USD Million)
TABLE 3. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Packaging Material, 2017-2032 (USD Million)
TABLE 4. Global Composite Materials Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Composite Materials Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Composite Materials Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Blister Foils Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Blister Foils Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Blister Foils Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Laminates Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Laminates Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Laminates Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Glass Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Glass Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Glass Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Borosilicate Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Borosilicate Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Borosilicate Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Soda Lime Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Soda Lime Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Soda Lime Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Metal Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Metal Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Metal Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Aluminum Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Aluminum Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Aluminum Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Tinplate Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Tinplate Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Tinplate Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Paperboard Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Paperboard Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Paperboard Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Coated Paperboard Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Coated Paperboard Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Coated Paperboard Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Folding Cartons Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Folding Cartons Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Folding Cartons Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Plastic Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Plastic Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Plastic Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global HDPE Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global HDPE Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global HDPE Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global LDPE Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global LDPE Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global LDPE Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Packaging Form, 2017-2032 (USD Million)
TABLE 50. Global Primary Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Primary Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Primary Packaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Ampoules Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Ampoules Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Ampoules Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Blister Packs Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Blister Packs Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Blister Packs Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Bottles Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Bottles Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Bottles Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Vials Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Vials Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Vials Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Secondary Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Secondary Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Secondary Packaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Cartons Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Cartons Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Cartons Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Inserts Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Inserts Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Inserts Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Trays Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Trays Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Trays Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Tertiary Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Tertiary Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Tertiary Packaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Pallets Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Pallets Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Pallets Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Shippers Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Shippers Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Shippers Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Drug Dosage Form, 2017-2032 (USD Million)
TABLE 87. Global Biologics Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Biologics Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Biologics Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Monoclonal Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Monoclonal Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Monoclonal Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Parenteral Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Parenteral Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Parenteral Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Infusion Bags Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Infusion Bags Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Infusion Bags Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Injectable Vials Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Injectable Vials Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Injectable Vials Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Solid Oral Dosage Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Solid Oral Dosage Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Solid Oral Dosage Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Capsules Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Creams Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Creams Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Creams Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Ointments Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Ointments Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Ointments Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Function, 2017-2032 (USD Million)
TABLE 124. Global Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Environmental Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Environmental Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Environmental Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Integrity Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Integrity Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Integrity Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Preservation Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Preservation Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Preservation Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Barrier Protection Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Barrier Protection Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Barrier Protection Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Controlled Atmosphere Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Controlled Atmosphere Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Controlled Atmosphere Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Protection Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Protection Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Protection Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Light Protection Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Light Protection Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Light Protection Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Mechanical Protection Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Mechanical Protection Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Mechanical Protection Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 152. Global Active Technologies Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Global Active Technologies Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. Global Active Technologies Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. Global Release Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Global Release Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. Global Release Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. Global Scavengers Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Global Scavengers Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. Global Scavengers Market Size, by Country, 2017-2032 (USD Million)
TABLE 161. Global Passive Technologies Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Global Passive Technologies Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. Global Passive Technologies Market Size, by Country, 2017-2032 (USD Million)
TABLE 164. Global Barrier Films Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Global Barrier Films Market Size, by Group, 2017-2032 (USD Million)
TABLE 166. Global Barrier Films Market Size, by Country, 2017-2032 (USD Million)
TABLE 167. Global Coatings Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Global Coatings Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. Global Coatings Market Size, by Country, 2017-2032 (USD Million)
TABLE 170. Global Smart Technologies Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Global Smart Technologies Market Size, by Group, 2017-2032 (USD Million)
TABLE 172. Global Smart Technologies Market Size, by Country, 2017-2032 (USD Million)
TABLE 173. Global IoT Enabled Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Global IoT Enabled Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. Global IoT Enabled Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 176. Global Printed Electronics Market Size, by Region, 2017-2032 (USD Million)
TABLE 177. Global Printed Electronics Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. Global Printed Electronics Market Size, by Country, 2017-2032 (USD Million)
TABLE 179. Global Pharmaceutical Active & Intelligent Packaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 180. Global Contract Packaging Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 181. Global Contract Packaging Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. Global Contract Packaging Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 183. Global Hospitals And Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 184. Global Hospitals And Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. Global Hospitals And Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 186. Global Pharmaceutical Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 187. Global Pharmaceutical Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 188. Global Pharmaceutical Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 189. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 190. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 192. Global Wholesale Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 193. Global Wholesale Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 194. Global Wholesale Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 195. Global Pharmaceutical Active & Intelligent Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 196. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 197. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Packaging Material, 2017-2032 (USD Million)
TABLE 198. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Composite Materials, 2017-2032 (USD Million)
TABLE 199. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Glass, 2017-2032 (USD Million)
TABLE 200. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Metal, 2017-2032 (USD Million)
TABLE 201. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Paperboard, 2017-2032 (USD Million)
TABLE 202. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Plastic, 2017-2032 (USD Million)
TABLE 203. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Packaging Form, 2017-2032 (USD Million)
TABLE 204. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Primary Packaging, 2017-2032 (USD Million)
TABLE 205. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Secondary Packaging, 2017-2032 (USD Million)
TABLE 206. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Tertiary Packaging, 2017-2032 (USD Million)
TABLE 207. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Drug Dosage Form, 2017-2032 (USD Million)
TABLE 208. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 209. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 210. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Solid Oral Dosage, 2017-2032 (USD Million)
TABLE 211. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Topical, 2017-2032 (USD Million)
TABLE 212. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Function, 2017-2032 (USD Million)
TABLE 213. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Monitoring, 2017-2032 (USD Million)
TABLE 214. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Preservation, 2017-2032 (USD Million)
TABLE 215. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Protection, 2017-2032 (USD Million)
TABLE 216. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 217. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Active Technologies, 2017-2032 (USD Million)
TABLE 218. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Passive Technologies, 2017-2032 (USD Million)
TABLE 219. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by Smart Technologies, 2017-2032 (USD Million)
TABLE 220. Asia-Pacific Pharmaceutical Active & Intelligent Packaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 221. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 222. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Packaging Material, 2017-2032 (USD Million)
TABLE 223. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Composite Materials, 2017-2032 (USD Million)
TABLE 224. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Glass, 2017-2032 (USD Million)
TABLE 225. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Metal, 2017-2032 (USD Million)
TABLE 226. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Paperboard, 2017-2032 (USD Million)
TABLE 227. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Plastic, 2017-2032 (USD Million)
TABLE 228. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Packaging Form, 2017-2032 (USD Million)
TABLE 229. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Primary Packaging, 2017-2032 (USD Million)
TABLE 230. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Secondary Packaging, 2017-2032 (USD Million)
TABLE 231. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Tertiary Packaging, 2017-2032 (USD Million)
TABLE 232. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Drug Dosage Form, 2017-2032 (USD Million)
TABLE 233. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 234. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 235. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Solid Oral Dosage, 2017-2032 (USD Million)
TABLE 236. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Topical, 2017-2032 (USD Million)
TABLE 237. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Function, 2017-2032 (USD Million)
TABLE 238. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Monitoring, 2017-2032 (USD Million)
TABLE 239. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Preservation, 2017-2032 (USD Million)
TABLE 240. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Protection, 2017-2032 (USD Million)
TABLE 241. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 242. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Active Technologies, 2017-2032 (USD Million)
TABLE 243. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Passive Technologies, 2017-2032 (USD Million)
TABLE 244. North America Pharmaceutical Active & Intelligent Packaging Market Size, by Smart Technologies, 2017-2032 (USD Million)
TABLE 245. North America Pharmaceutical Active & Intelligent Packaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 247. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Packaging Material, 2017-2032 (USD Million)
TABLE 248. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Composite Materials, 2017-2032 (USD Million)
TABLE 249. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Glass, 2017-2032 (USD Million)
TABLE 250. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Metal, 2017-2032 (USD Million)
TABLE 251. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Paperboard, 2017-2032 (USD Million)
TABLE 252. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Plastic, 2017-2032 (USD Million)
TABLE 253. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Packaging Form, 2017-2032 (USD Million)
TABLE 254. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Primary Packaging, 2017-2032 (USD Million)
TABLE 255. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Secondary Packaging, 2017-2032 (USD Million)
TABLE 256. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Tertiary Packaging, 2017-2032 (USD Million)
TABLE 257. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Drug Dosage Form, 2017-2032 (USD Million)
TABLE 258. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 259. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 260. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Solid Oral Dosage, 2017-2032 (USD Million)
TABLE 261. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Topical, 2017-2032 (USD Million)
TABLE 262. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Function, 2017-2032 (USD Million)
TABLE 263. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Monitoring, 2017-2032 (USD Million)
TABLE 264. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Preservation, 2017-2032 (USD Million)
TABLE 265. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Protection, 2017-2032 (USD Million)
TABLE 266. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 267. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Active Technologies, 2017-2032 (USD Million)
TABLE 268. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Passive Technologies, 2017-2032 (USD Million)
TABLE 269. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by Smart Technologies, 2017-2032 (USD Million)
TABLE 270. Latin America Pharmaceutical Active & Intelligent Packaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 271. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 272. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Packaging Material, 2017-2032 (USD Million)
TABLE 273. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Composite Materials, 2017-2032 (USD Million)
TABLE 274. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Glass, 2017-2032 (USD Million)
TABLE 275. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Metal, 2017-2032 (USD Million)
TABLE 276. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Paperboard, 2017-2032 (USD Million)
TABLE 277. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Plastic, 2017-2032 (USD Million)
TABLE 278. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Packaging Form, 2017-2032 (USD Million)
TABLE 279. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Primary Packaging, 2017-2032 (USD Million)
TABLE 280. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Secondary Packaging, 2017-2032 (USD Million)
TABLE 281. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Tertiary Packaging, 2017-2032 (USD Million)
TABLE 282. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Drug Dosage Form, 2017-2032 (USD Million)
TABLE 283. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 284. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 285. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Solid Oral Dosage, 2017-2032 (USD Million)
TABLE 286. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Topical, 2017-2032 (USD Million)
TABLE 287. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Function, 2017-2032 (USD Million)
TABLE 288. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Monitoring, 2017-2032 (USD Million)
TABLE 289. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Preservation, 2017-2032 (USD Million)
TABLE 290. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Protection, 2017-2032 (USD Million)
TABLE 291. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 292. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Active Technologies, 2017-2032 (USD Million)
TABLE 293. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Passive Technologies, 2017-2032 (USD Million)
TABLE 294. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by Smart Technologies, 2017-2032 (USD Million)
TABLE 295. Europe Pharmaceutical Active & Intelligent Packaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 296. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 297. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Packaging Material, 2017-2032 (USD Million)
TABLE 298. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Composite Materials, 2017-2032 (USD Million)
TABLE 299. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Glass, 2017-2032 (USD Million)
TABLE 300. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Metal, 2017-2032 (USD Million)
TABLE 301. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Paperboard, 2017-2032 (USD Million)
TABLE 302. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Plastic, 2017-2032 (USD Million)
TABLE 303. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Packaging Form, 2017-2032 (USD Million)
TABLE 304. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Primary Packaging, 2017-2032 (USD Million)
TABLE 305. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Secondary Packaging, 2017-2032 (USD Million)
TABLE 306. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Tertiary Packaging, 2017-2032 (USD Million)
TABLE 307. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Drug Dosage Form, 2017-2032 (USD Million)
TABLE 308. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 309. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 310. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Solid Oral Dosage, 2017-2032 (USD Million)
TABLE 311. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Topical, 2017-2032 (USD Million)
TABLE 312. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Function, 2017-2032 (USD Million)
TABLE 313. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Monitoring, 2017-2032 (USD Million)
TABLE 314. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Preservation, 2017-2032 (USD Million)
TABLE 315. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Protection, 2017-2032 (USD Million)
TABLE 316. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 317. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Active Technologies, 2017-2032 (USD Million)
TABLE 318. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Passive Technologies, 2017-2032 (USD Million)
TABLE 319. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by Smart Technologies, 2017-2032 (USD Million)
TABLE 320. Middle East Pharmaceutical Active & Intelligent Packaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 321. Africa Pharmaceutical Active & Intelligent Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 322. Africa Pharmaceutical Active & Intelligent Packaging Market Size, by Packaging Material, 2017-2032 (USD Million)
TABLE 323. Africa Pharmaceutical Active & Intelligent Packaging Market Size, by Composite Materials, 2017-2032 (USD Million)
TABLE 324. Africa Pharmaceutical Active & Intelligent Packaging Market Size, by Glass, 2017-2032 (USD Million)
TABLE 325. Africa Pharmaceutical Active & Intelligent Packaging Market Size, by Metal, 2017-2032 (USD Million)
TABLE 326. Africa Pharmaceutical Active & Intelligent Packaging Market Size, by Paperboard, 2017-2032 (USD Million)
TABLE 327. Africa Pharmaceutical Active & Intelligent Packaging Market Size, by Plastic, 2017-2032 (USD Million)
TABLE 328. Africa Pharmaceutical Active & Intelligent Packaging Market Size, by Packaging Form, 2017-2032 (USD Million)
TABLE 329. Africa Pharmaceutical Active & Intelligent Packaging Market Size, by Primary Packaging, 2017-2032 (USD Million)
TABLE 330. Africa Pharmaceutical Active & Intelligent Packaging Market Size, by Secondary Packaging, 2017-2032 (USD Million)
TABLE 331. Africa Pharmaceutical Active & Intelligent Packaging Market Size, by Tertiary Packaging, 2017-2032 (USD Million)
TABLE 332. Africa Pharmaceutical Active & Intelligent Packaging Market Size, by Drug Dosage Form, 2017-2032 (USD Million)
TABLE 333. Africa Pharmaceutical Active & Intelligent Packaging Market Size, by Biologics, 2017-2032 (

Companies Mentioned

  • Amcor plc
  • Avery Dennison Corporation
  • Berry Global Group, Inc.
  • CCL Industries Inc.
  • Constantia Flexibles GmbH
  • Coveris Holdings SA
  • Huhtamäki Oyj
  • Schreiner Group GmbH & Co. KG
  • Sealed Air Corporation
  • Sonoco Products Company
  • Tetra Pak International S.A.
  • Uflex Limited

Related Topics

Related Reports

Sustainable Pharmaceutical Packaging Market - Global Forecast 2026-2032 - Product Image

Sustainable Pharmaceutical Packaging Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Temperature Controlled Package for Pharmaceutical Market - Global Forecast 2026-2032 - Product Image

Temperature Controlled Package for Pharmaceutical Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Pharmaceuticals Temperature Controlled Packaging Solutions Market - Global Forecast 2026-2032 - Product Image

Pharmaceuticals Temperature Controlled Packaging Solutions Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Ampoules Market - Global Forecast 2026-2032 - Product Image

Ampoules Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Blister Packaging Lines Market - Global Forecast 2026-2032 - Product Image

Blister Packaging Lines Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.